Research Coverage- Viking Therapeutics (VKTX)
This is meant as a scientific/business development post as to the merits of VKTX. It is well known VKTX is undervalued (by upwards of 40x), but these details will not be discussed here. For a more detailed valuation analysis, see the end of Zacks SCR’s post.
Background
Viking Therapeutics is a clinical stage biopharmaceutical....More>>>